FDx Advisors Inc. Has $538,000 Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)
FDx Advisors Inc. increased its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Rating) by 16.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,098 shares of the company’s stock after buying an additional 1,013 shares during the […]